Pulsatile Cuts Stendo3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pulsatile Cuts Stendo3, covering 2018-07-16 to 2018-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2 [NA]